Table 3.
Attitude of HCPs towards ADR-reporting in Nekemte town from January 2015 to June 2015.
| Variable | Category | Frequency | % |
|---|---|---|---|
| ADR-reporting essential | Agree | 103 | 77.4 |
| Disagree | 6 | 4.5 | |
| Neutral | 24 | 18.1 | |
|
| |||
| Reporting encouraged when | Reaction is serious | 58 | 43.6 |
| Unusual reaction | 33 | 24.8 | |
| You are certain | 31 | 23.3 | |
| Every one of each | 11 | 8.3 | |
|
| |||
| Premarket drug evaluation enough | Yes | 21 | 15.7 |
| No | 63 | 47.5 | |
| Neutral | 49 | 36.8 | |
|
| |||
| Yellow card reporting cost effective | Yes | 46 | 34.8 |
| No | 13 | 9.8 | |
| Neutral | 74 | 55.6 | |
|
| |||
| ADR reporting | Compulsory | 77 | 57.9 |
| Voluntary | 38 | 28.6 | |
| Neutral | 18 | 13.5 | |